+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Basic Fundamentals of Drug Delivery. Advances in Pharmaceutical Product Development and Research

  • Book

  • December 2018
  • Elsevier Science and Technology
  • ID: 4622074

Basic Fundamentals of Drug Delivery covers the fundamental principles, advanced methodologies and technologies employed by pharmaceutical scientists, researchers and pharmaceutical industries to transform a drug candidate or new chemical entity into a final administrable drug delivery system. The book also covers various approaches involved in optimizing the therapeutic performance of a biomolecule while designing its appropriate advanced formulation.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Scientific rationale for designing controlled drug delivery systems 2. Current developments in excipient science: Implication of quantitative selection of each excipient in product development 3. Fundamentals of polymers science applied in Pharmaceutical Product Development 4. Use of polymers in controlled release of active agents 5. Co-polymers and block co-polymers in drug delivery and therapy 6. Pharmaceutical and biomedical applications of polymers 7. Levels of Drug targeting 8. Ligands for targeted drug delivery and applications 9. Transportation and bio interaction Properties in nanomaterials across biological systems 10. Importance of preliminary characterisation of nanoparticles in pharmaceutical product development 11. Biodegradable Block Copolymers and Their Applications For Drug Delivery 12. Bio-Nanotechnology in pharmaceutical research 13. Design and evaluation of ophthalmic delivery formulations 14. Design and fabrication of Brain targeted drug delivery 15. Cutaneous and transdermal drug delivery: Techniques and Delivery systems 16. Protein/peptide drug delivery systems: Practical considerations in Pharmaceutical Product Development 17. Nanocarriers in different preclinical and clinical stages 18. Clinical aspects and regulatory requirements for nanomedicines